Login / Signup

Cardiac and noncardiac biomarkers in patients undergoing anthracycline chemotherapy - a prospective analysis.

Matthew DeanMin Jung KimSharon DimauroSusan TannenbaumGarth GrahamBruce T LiangAgnes S Kim
Published in: Cardio-oncology (London, England) (2023)
The results identify biomarkers with significant interval changes in response to anthracycline therapy. Further research is needed to understand the clinical utility of these novel biomarkers.
Keyphrases
  • patients undergoing
  • heart failure
  • stem cells
  • left ventricular
  • atrial fibrillation
  • locally advanced